Global Nanomaterials In Personalized Medicine Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Nanomaterials In Personalized Medicine Industry Market Size Be by 2025?
The market for nanomaterials in personalized medicine has seen rapid expansion in recent years. Its size is projected to increase from $351.41 billion in 2024 to $392.97 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this growth during the historical period include the rising use of nanotechnology in medication delivery, escalating demand for targeted treatments, increased understanding of the advantages of personalized medicine, extensive research in biomarker identification, and the growing incidence of chronic illnesses.

What's the Long-Term Growth Forecast for the Nanomaterials In Personalized Medicine Market Size Through 2029?
The market size of nanomaterials in personalized medicine is poised for a swift expansion in the forthcoming years, with predictions showing it could reach $606.39 billion in 2029 at a CAGR of 11.5%. This anticipated growth during the forecast period can be credited to numerous factors such as rising demand for specific medicine, boosts in government funding for nanomedicine, burgeoning partnerships between biotechnology and pharmaceutical firms, an uptick in the acceptance of sophisticated diagnostic tools, and an increasing emphasis on patient-dedicated treatments. The forecast period will likely witness major trends such as enhancements in nanoparticle design technology, evolution in nano-based drug recipes, inventive targeted delivery systems, increases in research investment, development of personalized therapies, and advancements in hybrid nanomaterials for healthcare applications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

What Are the Key Growth Drivers Fueling the Nanomaterials In Personalized Medicine Market Expansion?
The growth of the nanomaterials in personalized medicine market appears to be fueled by a rising demand for personalized medicine. This medical approach customizes treatments based on an individual's genetic, environmental, and lifestyle factors with the aim to maximize results and enhance patient care. The surge in demand for personalized medicine is chiefly due to developments in genomic technologies. These advancements enable detailed identification of genetic variations and bespoke treatment plans for individuals. Nanomaterials play a crucial role in personalized medicine by facilitating patient-specific and targeted treatments, thereby improving the safety and effectiveness of these treatments. They ensure accurate delivery of medicaments, genes or RNA, minimize adverse effects, and maximize therapeutic results. A case in point is the US-based nonprofit organization, the Personalized Medicine Coalition (PMC)'s report from February 2024, which stated that the U.S. Food and Drug Administration (FDA) had granted approval to 26 new personalized medicines in 2023. This figure reflects a notable climb from the 12 approvals in 2022. Hence, the escalating demand for personalized medicine is indeed catalyzing the growth of the nanomaterials in personalized medicine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

What Are the Key Trends Driving Nanomaterials In Personalized Medicine Market Growth?
Top-tier entities in the nanomaterials in personalized medicine arena are taking on strategic affiliations as a way to spur clinical transition, diversify therapeutic uses, and decrease time-to-market, all the while complying with adaptable regulatory guidelines. These strategic affiliations denote partnerships in which organizations or institutions amalgamate their specialties and assets to speed up innovation and grow opportunities in the personalized medicine sector. Take for example in May 2025, Acuitas Therapeutics Inc., a biotechnology firm based in Canada, joined forces with Integrated DNA Technologies Inc, a genomics solutions company situated in the US. They launched a personalized CRISPR gene-editing therapy delivery using their lipid nanoparticles platform which was able to treat a baby with a rare genetic disorder by delivering precisely targeted CRISPR payloads, bespoke dose tuning, and quick, custom formulation. This breakthrough expedites unique, highly customized treatments, enhances therapeutic accuracy and patient outcomes, but at the same time, introduces challenges in scalable production, stringent regulatory tailoring, and ultra-low-volume manufacturing.

How Is the Nanomaterials In Personalized Medicine Market Segmented?
The nanomaterials in personalized medicine market covered in this report is segmented as

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles
2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery
3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods
4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines
5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:
1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots
2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles
3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels
4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods
5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28276&type=smp

Which Companies Are Leading the Charge in Nanomaterials In Personalized Medicine Market Innovation?
Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Which Regions Are Leading the Global Nanomaterials In Personalized Medicine Market in Revenue?
North America was the largest region in the nanomaterials in personalized medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nanomaterials in personalized medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28276

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.